Maxim Group Reiterates Buy Rating for Galena Biopharma Inc
's stock had its "buy" rating restated by equities researchers at Maxim Group in a research note issued to investors on Tuesday, MarketBeat.Com reports. Other equities research analysts also recently issued research reports about the company.
from Biotech News
0 Comments